Key Insights

Highlights

Treatment Research

2 treatments under study, led by Carotid Artery Stenting

Research Leaders

11 sponsors active, led by Xuanwu Hospital, Beijing

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05028855Unknown

Cerebral Autoregulation in Patients With Symptomatic Cerebral Atherosclerotic Stenosis

NCT06058676UnknownPrimary

Prediction of Hyperperfusion After Carotid Stenting by Multi-parameter Characteristics Based on Cerebral Autoregulation

Showing all 2 trials

Research Network

Common Treatments

  • Carotid Artery Stenting1
  • Cerebral Autoregulation Assessment1

Active Sponsors

  • Xuanwu Hospital, Beijing1
  • Yi Yang1
  • The First Affiliated Hospital of University of South China1
  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital1
  • Eighth Affiliated Hospital, Sun Yat-sen University1

Top Investigators

  • yingqi Xing, MD1

    Department of Vascular Ultrasonography, Xuanwu Hospital. Beijing Institute of Brain Disorders.

  • Yi Yang, MD, PhD1

    Neuroscience Center, Department of Neurology, The First Hospital of Jilin University

Related Conditions

  • Carotid Artery Stent1
  • Dynamic Cerebral Autoregulation1
  • Cerebrovascular Stroke1

Activity Timeline